國藝娛樂(08228.HK) 重組方案獲99.9%股東支持通過
國藝娛樂(08228.HK)宣布,公司就財務重組增設額外新股份、發行新股份及可換股債券,日前獲得99.9%股東支持通過,公司重組將進入下一階段並將舉行債權人會議,至今重組方案已獲大量債權人支持。
公司重組程式現已進入法律程式,為重組可以盡快完成,公司將配合有關聆訊進度,於2019年11月8日舉行債權人會議進行投票,只待重組方案獲於會議上獲必要大多數債權人支持,重組將隨即進入餘下所需法律程序,以便可如期完成重組。公司至今已獲大量債權人交回填妥及簽立的加盟契據,表示支持重組,相信未來極大機會可於債權人會議順利通過重組方案。 ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.